Rapid development of IRIS in the form of cryptococcal meningitis after beginning ART

Medical Mycology Case Reports

Volumn 1, Issue 1, 2012, Pages 56-58

  Malik, Abida ^a   Khan, Parvez A ^a   Shujatullah, Fatima ^a   Fatima, Nazish ^a   Shameem, M ^a   Siddiqui, Azfar ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

Anti retroviral therapy (ART); Cryptococcal meningitis; Immune reconstitution inflammatory syndrome (IRIS)

Indexed keywords

EFAVIRENZ; ETHAMBUTOL; ISONIAZID; LAMIVUDINE; PYRAZINAMIDE; RIFAMPICIN; STAVUDINE;

ADULT; ANEMIA; ANTIGEN DETECTION; ANTIRETROVIRAL THERAPY; ARTICLE; BACTERIUM DETECTION; BLOOD ANALYSIS; BLOOD CULTURE; BLOOD PRESSURE MEASUREMENT; BODY TEMPERATURE; CASE REPORT; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; COUGHING; CRYPTOCOCCAL MENINGITIS; DETERIORATION; FEVER; FILOBASIDIELLA; HEADACHE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; LEUKOPENIA; LUMBAR PUNCTURE; LUNG TUBERCULOSIS; LYMPHOCYTE COUNT; MALE; MEDICAL HISTORY; NEUTROPHIL COUNT; PRIORITY JOURNAL; SPUTUM EXAMINATION; THORAX RADIOGRAPHY; TREATMENT REFUSAL; VOMITING;

EID: 84865328949     PISSN: 22117539     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mmcr.2012.07.002     Document Type: Article

References (22)

1. Navas, E, Martin-Davila, P, Moreno, L, Paradoxical reactions of tuber-culosis in patients with the acquired immunodeficiency syndrome who are treated with highly active antiretroviral therapy. Archives of Internal Medicine 162 (2002), 97–99.
2. DeSimone, JA, Pomerantz, RJ, Babinchak, TJ, Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy. Annals of Internal Medicine 133 (2000), 447–454.
3. Lanzafame, M, Trevenzoli, M, Carreetta, G, et al. Mediastinal lymphadenitis due to cryptococcal infection in HIV-positive patients on highly active antiretroviral therapy. Chest 116 (1999), 848–849.
4. Boelaert, JR, Goddeeris, KH, Vanopdenbosch, LJ, Casselman, JW, Relapsing meningitis caused by persistent cryptococcal antigensand immune reconstitution after the initiation of highly active antiretroviraltherapy. AIDS 18 (2004), 1223–1224.
5. King, MD, Perlino, CA, Cinnamon, J, Jernigan, JA, Paradoxical recurrent meningitis following therapy of cryptococcal meningitis: an immune reconstitution syndrome after initiation of highly active antiretroviraltherapy. International Journal of STD & AIDS 13 (2002), 724–726.
6. Woods, ML II, MacGinley, R, Eisen, DP, Allworth, AM, HIV combination therapy: partial immune restitution unmasking latent cryptococcalinfection. AIDS 12 (1998), 1491–1494.
7. Antinori, S, Ridolfo, A, Fasan, M, Magni, C, Galimberti, L, Milazzo, L, Sollima, S, Adorni, F, Giuliani, G, Galli, M, Corbellino, M, Parravicini, C, AIDS-associated cryptococcosis: a comparison of epidemiology,clinical features and outcome in the pre- and post-HAART eras. Experienceof a single centre in Italy. HIV Medicine 10 (2009), 6–11.
8. Lawn, SD, Bekker, LG, Myer, L, Orrell, C, Wood, R, Cryptococcocal immune reconstitution disease: a major cause of early mortality in a South African antiretroviral programme. AIDS 19 (2005), 2050–2052.
9. Shelburne, SA 3rd, Darcourt, J, White, AC Jr, et al. The role of immune reconstitution inflammatory syndrome AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy. Clinical Infectious Diseases 40 (2005), 1049–1052.
10. Shelburne, SA, Visnegarwala, F, Darcourt, J, et al. Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS 19 (2005), 399–406.
11. Shelburne, SA, Darcourt, J, White, AC Jr, Greenberg, SB, Hamill, RJ, Atmar, RL, Visnegarwala, F, The role of immunereconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy. Clinical Infectious Diseases 40 (2005), 1049–1105.
12. Sungkanuparph, S, Jongwutiwes, U, Kiertiburanakul, S, Timing of cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in patients with AIDS and cryptococcal meningitis. Journal of Acquired Immune Deficiency Syndromes 45 (2007), 595–596.
13. Perfect, JR, Dismukes, WE, Dromer, F, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of America. Clinical Infectious Diseases 50:3 (2010), 291–322.
14. Jenny-Avital, ER, Abadi, M, Immune reconstitution cryptococcosisafter initiation of successful highly active antiretroviraltherapy. Clinical Infectious Diseases 35:12 (2002), e128–e133.
15. Bicanic, T, Harrison, T, Niepieklo, A, Dyakopu, N, Meintjes, G, Symptomatic relapse of HIV-associated cryptococcal meningitisafter initial fluconazole monotherapy: the role of fluconazoleresistance and immune reconstitution. Clinical Infectious Diseases 43:8 (2006), 1069–1073.
16. Woods, ML, MacGinley, R, Eisen, D, Allworth, AM, HIV combination therapy: partial immune reconstitution unmasking latent cryptococcal infection. AIDS 12 (1998), 1491–1494.
17. Lortholary, O, Fontanet, A, Memain, N, Martin, A, Sitbon, K, Dromer, F, Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France. AIDS 19:10 (2005), 1043–1049.
18. Shankar, EM, Vignesh, R, Velu, V, et al. Does CD4+CD25+foxp3+ cell (Treg) and IL-10 profile determine susceptibility to immune reconstitution inflammatory syndrome (IRIS) in HIV disease?. Journal of Inflammation (London), 5, 2008, 2.
19. King, MD, Perlino, CA, Cinnamon, J, Jernigan, JA, Paradoxical recurrent meningitis following therapy of cryptococcal meningitis: an immune reconstitution syndrome after initiation of highly active antiretroviral therapy 13:10 (2002), 724–726 International Journal of STD & AIDS 13:10 (2002), 724–726.
20. Manfredi, R, Pieri, SA, Stefano, AP, Chiodo, F, The changing face of AIDS-related opportunism:Cryptococcosis in the highly active antiretroviral therapy (HAART) era. Case reports and literature review. Mycopathologia 148 (1999), 73–78.
21. Meintjes G, Wilkinson RJ, Morroni C, Pepper DJ, Rebe K, Rangaka MX, et al. Randomized placebo-controlled trial of prednisone for TB IRIS; Conference on Retroviruses and Opportunistic Infections; 2009.
22. Saag, MS, Graybill, RJ, Larsen, RA, Pappas, PG, Perfect, JR, Powderly, WG, et al. Practice guidelines for the management of cryptococcal disease. Clinical Infectious Diseases 30 (2000), 710–718.